Featured
Cramer Predicts Volatility as Tech Earnings, Midterms Loom
Health Policy Desk Oct 31, 2026
Wellness Roundtable Oct 30, 2026
Pharma Pipeline Oct 29, 2026
Tech insiders surprisingly favor Eli Lilly stock over tech stocks, with predictions of a $2...
Restaurant stocks have split sharply this year, with multi-brand groups like Brinker International and Darden...
Ukraine faces unopposed Russian ballistic strikes after running out of Patriot missiles, as Zelenskyy warns...
Read our latest Health Policy Desk articles.
Jim Cramer warns of continued market volatility as tech earnings season and midterm elections approach,...
Wonder expands into Texas with an automation push as it considers an IPO.
Ukraine faces Starlink restrictions, limiting military defense capabilities with speed limits on Starshield.
Jim Cramer warns of continued market volatility as tech earnings season and midterm elections approach, with tech stocks under pressure and the Nasdaq dropping
Jim Cramer warns of continued market volatility as tech earnings season and midterm elections approach, with tech stocks under pressure...
Burger King's U.S. growth offsets Popeyes' slump in mixed results, with same-store sales growth of 3.8% across all locations.
Alphabet stock plummets after missing earnings expectations, triggering a steep sell-off.
Honda executives warned that a proposed 50% Canada tariffs on Canadian cars and parts could devastate the auto sector, urging...
Tech insiders surprisingly favor Eli Lilly stock over tech stocks, with predictions of a $2 trillion market cap.
Wonder expands into Texas with an automation push as it considers an IPO.
Brazil's President Luiz Inácio Lula da Silva and Senator Flavio Bolsonaro rally supporters before presidential runoff on Sunday.
Ukraine faces Starlink restrictions, limiting military defense capabilities with speed limits on Starshield.
Restaurant stocks have split sharply this year, with multi-brand groups like Brinker International and Darden Restaurants gaining ground while single...
The bipartisan Faster Clinical Trials Act aims to accelerate rare disease trials by encouraging computer simulations in early-stage drug development.